(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(0.33%) $78.37
(0.84%) $2.16
(-0.19%) $2 304.30
(0.05%) $26.70
(-0.53%) $960.15
(0.10%) $0.930
(-0.05%) $10.87
(0.06%) $0.798
(0.00%) $91.45
3 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 3.95%
-3.37% $ 0.430
Live Chart Being Loaded With Signals
Spectral Medical Inc., together with its subsidiaries, focuses on the development and commercialization of products for the treatment of septic shock and renal disease in North America...
Stats | |
---|---|
Dzisiejszy wolumen | 5 317.00 |
Średni wolumen | 80 176.00 |
Kapitalizacja rynkowa | 119.79M |
EPS | $0 ( 2024-03-25 ) |
Następna data zysków | ( $0 ) 2024-05-09 |
Last Dividend | $0.120 ( 2011-12-19 ) |
Next Dividend | $0 ( N/A ) |
P/E | -7.17 |
ATR14 | $0 (0.00%) |
Spectral Medical Inc Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Spectral Medical Inc Finanse
Annual | 2023 |
Przychody: | $1.60M |
Zysk brutto: | $-4.81M (-301.06 %) |
EPS: | $-0.0562 |
FY | 2023 |
Przychody: | $1.60M |
Zysk brutto: | $-4.81M (-301.06 %) |
EPS: | $-0.0562 |
FY | 2022 |
Przychody: | $1.67M |
Zysk brutto: | $983 000 (58.97 %) |
EPS: | $-0.0419 |
FY | 2021 |
Przychody: | $2.05M |
Zysk brutto: | $1.22M (59.45 %) |
EPS: | $-0.0300 |
Financial Reports:
No articles found.
Spectral Medical Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.120 | 2011-12-19 |
Last Dividend | $0.120 | 2011-12-19 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | $0.120 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.01 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
2011 | $0 | 0.00% |
2012 | $0 | 0.00% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
XFN.TO | Dividend Knight | 2023-08-25 | Monthly | 24 | 1.94% | |
PRA.TO | Dividend Junior | 2023-06-27 | Quarterly | 12 | 1.15% | |
FCUH.TO | Dividend Knight | 2023-07-26 | Monthly | 7 | 1.60% | |
ZWB.TO | Dividend King | 2023-08-29 | Monthly | 14 | 3.78% | |
TRI.TO | Dividend King | 2023-06-23 | Quarterly | 17 | 2.02% | |
MCSB.TO | Dividend Knight | 2023-09-01 | Monthly | 8 | 1.37% | |
CSU.TO | Dividend Knight | 2023-09-19 | Quarterly | 17 | 0.16% | |
XQQ.TO | Dividend Junior | 2023-06-26 | Semi-Annually | 14 | 0.17% | |
RCD.TO | Dividend King | 2023-09-21 | Monthly | 11 | 2.31% | |
FXM.TO | Dividend Junior | 2023-09-22 | Quarterly | 13 | 1.54% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -9.76 | 1.500 | -10.00 | -10.00 | [0 - 0.5] |
returnOnAssetsTTM | -2.99 | 1.200 | -10.00 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | 1.629 | 1.500 | 10.00 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0.403 | 0.800 | -2.99 | -2.39 | [1 - 3] |
quickRatioTTM | 0.366 | 0.800 | -2.55 | -2.04 | [0.8 - 2.5] |
cashRatioTTM | 0.288 | 1.500 | 9.51 | 10.00 | [0.2 - 2] |
debtRatioTTM | 1.547 | -1.500 | 10.00 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -8.77 | 1.000 | -4.36 | -4.36 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.0385 | 2.00 | -0.0128 | -0.0257 | [0 - 30] |
freeCashFlowPerShareTTM | -0.0391 | 2.00 | -0.0196 | -0.0391 | [0 - 20] |
debtEquityRatioTTM | -0.487 | -1.500 | -1.948 | 2.92 | [0 - 2.5] |
grossProfitMarginTTM | -0.321 | 1.000 | -8.68 | -8.68 | [0.2 - 0.8] |
operatingProfitMarginTTM | -7.32 | 1.000 | -10.00 | -10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -1.330 | 1.000 | -8.50 | -8.50 | [0.2 - 2] |
assetTurnoverTTM | 0.307 | 0.800 | -1.289 | -1.031 | [0.5 - 2] |
Total Score | -3.25 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -7.68 | 1.000 | -0.876 | 0 | [1 - 100] |
returnOnEquityTTM | 1.629 | 2.50 | 10.00 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.0391 | 2.00 | -0.0130 | -0.0391 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.0385 | 2.00 | -0.0128 | -0.0257 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.0536 | 1.500 | -2.98 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -6.71 | 1.000 | -10.00 | 0 | [0.1 - 0.5] |
Total Score | -0.539 |
Spectral Medical Inc
Spectral Medical Inc., together with its subsidiaries, focuses on the development and commercialization of products for the treatment of septic shock and renal disease in North America. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies; and develops platform for renal replacement therapy. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej